ArticleFrontiers in oncology2023

Case report: Complete pathological admission in N3 unresectable locally advanced lung adenocarcinoma with a novel INTS10-ALK and EML4-ALK fusion after neoadjuvant crizotinib.

Xiaoqian Zhai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.